Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To explore the safety of orally delivered rhIL-11 in patients with mild to moderate
left-sided ulcerative colitis.
To explore the effects of orally administered rhIL-11 on pharmacogenomics in blood samples
and in colonic biopsy tissue samples.